281195-35-5

Basic information

• Product Name: 4-(hexyloxy)-3-nitrobenzoic acid
• Synonyms: 4-(hexyloxy)-3-nitrobenzoic acid
• CAS NO: 281195-35-5
• Molecular Formula: C₁₃H₁₇NO₅
• Molecular Weight: 267.28
• Mol File: 281195-35-5.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 4-(hexyloxy)-3-nitrobenzoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(hexyloxy)-3-nitrobenzoic acid(281195-35-5)
• EPA Substance Registry System: 4-(hexyloxy)-3-nitrobenzoic acid(281195-35-5)

Safety Data

• Hazardous Substances Data: 281195-35-5(Hazardous Substances Data)

Upstream product

• 616-82-0 3-nitro-4-hydroxybenzoic acid 
• 19013-10-6 ethyl 4-hydroxy-3-nitrobenzoate 

Relevant articles and documents

NORVALINE DERIVATIVE AND METHOD FOR PREPARATION THEREOF

Norvaline derivative of the formula [I] or pharmaceutically acceptable salt thereof, method for preparing the same, pharmaceutical composition containing the same, and use of said compound for inhibiting transporting activity of glycine transporter type 2 (GlyT2). [wherein X is -CH2-, -O-, -S- or single bond; Ar is optionally substituted aryl or lower cycloalkyl; n is 0 to 2; R1 and R2 are (i) each is hydrogen or lower alkyl; (ii) R1 and R2 are combined to form lower alkylene; or (iii) R1 is hydrogen or lower alkyl and R2 is combined with R4 or R6 to form lower alkylene; R3 and R4 are (i) each is hydrogen or lower alkyl; (ii) R3 and R4 are combined to form lower alkylene; or (iii) R3 is hydrogen or lower alkyl and R4 is combined with R2 or R6 to form lower alkylene; R is or -OR7; R 5 and R6 are (i) each is optionally substituted lower alkyl, or hydrogen; (ii) R5 and R6 are combined to form aliphatic 5- to 6-membered heterocyclic group; or (iii) R5 is optionally substituted lower alkyl or hydrogen and R6 is combined with R2 or R4 to form lower alkylene; R7 is lower alkyl.

Columnar mesophase in a novel series of banana-shaped compounds consisting of functional nitro groups

A novel series of banana-shaped compounds with the following molecular structure has been synthesized and characterized. All the compounds synthesized in this series are found to be liquid crystalline forming a B1 phase, which has recently been designated as a columnar phase. The liquid crystalline behaviour of these compounds has been investigated by using the polarizing optical microscopy, differential scanning calorimetry and x-ray studies. The lower homologues of this series are monotropic whereas the higher ones are enantiotropic. We found that introduction of the nitro functional groups affects the mesomorphic properties in comparison to their respective unsubstituted compounds. The lower homologues of the unsubstituted ones exhibit a B1 phase whereas the higher ones a B2 phase.